ebook Munafa Stock Market Course + Intraday & FNO calls  

       

EMCURE NEWS why is Emcure Pharmaceuticals L price falling or rising

EMCURE NEWS reasons for why stock price of Emcure Pharmaceuticals L is falling or rising

EMCURE Emcure Pharmaceuticals is falling or rising technical reasons

Technical analysis forecast of Emcure Pharmaceuticals Stock is that its in a uptrend for shortterm, and I will avoid taking a SHORT or SELL trade in this stock. Look for opportunities to BUY or go LONG in Emcure Pharmaceuticals EMCURE at this time. Stock is rising and might rise more.

It appears as if Emcure Pharmaceuticals EMCURE gave a large move recently.

Stock of Emcure Pharmaceuticals (EMCURE) is trading above an important moving average line, but it crossed this line recently, which means that it could show a small or a large fall soon enough depending on its trend.

My analysis of Emcure Pharmaceuticals is bullish for shortterm, but trade for tomorrow is selective. Take a BUY trade only if Emcure Pharmaceuticals stays above 1414.9, but if it comes below 1414.9, then a intra day sell could be more profitable.
If you take a sell trade below 1414.9, then use 1414.9 as stoploss and 1390.21 as target. However if you take a buy trade in Emcure Pharmaceuticals, then use 1414.9 as stoploss and 1444.5 as target.

EMCURE Emcure Pharmaceuticals is falling or rising NEWS fundamental reasons

Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Schedule of meet - NEWS as on 2025-12-02

Emcure Pharma shares in focus after GST Department conducts search at Mumbai offices Emcure Pharmaceuticals' shares could see action following a Goods and Services Tax search at its Mumbai offices. The inspection concluded this week. The company recently reported a robust rise in revenue and profit after tax. Domestic and international bus - NEWS as on 2025-11-28 indiatimes.com

Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Action(s) initiated or orders passed - NEWS as on 2025-11-27

Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange regarding Resignation of Mr Chetan Sharma as Company Secretary & Compliance Officer of the company w.e.f. November 24, 2025. - NEWS as on 2025-11-24

Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Investor Presentation - NEWS as on 2025-11-19

Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange regarding 'Intimation of receipt of No-objection Letter for reclassification of shareholding from Promoter and Promoter Group category to Public category, in accordance with Regulation 31A of the - NEWS as on 2025-11-18

Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Transcript - NEWS as on 2025-11-18

Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication - NEWS as on 2025-11-14

Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange about Link of Recording - NEWS as on 2025-11-12

Company Announcement Emcure Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025. - NEWS as on 2025-11-11

Company Announcement Emcure Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 10, 2025, titled "Novo Nordisk India partners with Emcure Pharma to commercialise PoviztraŽ in India as a second brand of WegovyŽ". - NEWS as on 2025-11-10

Company Announcement - NEWS as on 2025-11-04

More announcements and NEWS

EMCURE Emcure Pharmaceuticals L current price & indicator signals

Moving Averages for Emcure Pharmaceuticals L

  • 5Day Average: 1398.28
  • 12Day Average: 1401.95
  • 20Day Average: 1387.65
  • 50Day Average: 1368.11
  • 100Day Average: 1382.38
  • 150Day Average: 1340.89
  • 200Day Average: 1254.99

EMCURE Indicators & signals

Indicator MACD (12,26,9)

1396.86, 1386.21, 10.36
Indicator MACD is in positive zone

Indicator ADX (14)

28.43, 26.89, 14.99
Indicator ADX is indicating that momentum is weak.
Indicator ADX is showing that momentum is towards buying

Indicator RSI (14)

Current RSI is: 52
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of EMCURE Emcure Pharmaceuticals L are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
09 Tue Dec 2025 1415.70 1377.00 to 1445.00 2.33% 1.24 times
08 Mon Dec 2025 1383.50 1379.20 to 1399.90 -0.91% 0.92 times
05 Fri Dec 2025 1396.20 1385.00 to 1404.00 -0.52% 0.74 times
04 Thu Dec 2025 1403.50 1379.10 to 1429.90 0.79% 0.73 times
03 Wed Dec 2025 1392.50 1386.50 to 1410.80 0.06% 0.27 times
02 Tue Dec 2025 1391.60 1380.80 to 1433.00 -2.96% 0.72 times
01 Mon Dec 2025 1434.10 1414.30 to 1442.60 1.4% 0.45 times
28 Fri Nov 2025 1414.30 1398.10 to 1434.40 0.21% 0.86 times
27 Thu Nov 2025 1411.40 1391.00 to 1418.40 1.02% 1.72 times
26 Wed Nov 2025 1397.20 1312.30 to 1412.50 -1.71% 1.34 times
25 Tue Nov 2025 1421.50 1350.60 to 1429.00 4.38% 2.25 times
24 Mon Nov 2025 1361.90 1345.20 to 1382.90 0.54% 1.55 times

Videos related to: EMCURE NEWS why is Emcure Pharmaceuticals L price falling or rising

Hindi Basics How To Trade In FnO Futures Options Stock Market

EMCURE NEWS why is Emcure Pharmaceuticals L price falling or rising

 

Back to top